About

The MIT Center for Biomedical Innovation (CBI) improves global health by overcoming obstacles to the development and implementation of biomedical innovation. CBI provides a safe and transparent environment for collaborative research among industry, academia, and government and draws on the expertise of the MIT Schools of Engineering, Science, and Management as well as the Harvard-MIT Division of Health Sciences and Technology (HST).

In this unique setting, CBI is addressing profound challenges in the global biomedical industry by developing, testing, and disseminating new knowledge and tools designed for real–world application through the following research programs:

  1. Biomanufacturing Research Program (BioMAN)
  2. The Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB)
  3. New Drug Development Paradigms (NEWDIGS)

Leadership

Gigi Hirsch
Executive Director, CBI
Program Director, NEWDIGS
ghirsch@mit.edu
617.253.6909

Stacy Springs
Executive Director, BioMAN
Executive Director, CAACB
Director, MIT–Sanofi Alliance
ssprings@mit.edu
617.253.3084

Anthony Sinskey
Faculty Director, CBI
Professor of Microbiology & Engineering Systems
Professor of Health Sciences and Technology
asinskey@mit.edu
617.253.6721